Racial disparity in receipt of immunotherapy treatment among elderly patients with head and neck cancer.
Osazuwa-Peters N, Abouelella D, Bhardwaj A, Patel A, Hussaini A, Seetharaman K, Barnes J, Panth N, Boakye E, Watts T. Racial disparity in receipt of immunotherapy treatment among elderly patients with head and neck cancer. Journal Of Clinical Oncology 2022, 40: 6049-6049. DOI: 10.1200/jco.2022.40.16_suppl.6049.Peer-Reviewed Original ResearchHead and neck cancerReceipt of immunotherapyNeck cancerElderly patientsImmunotherapy useTreatment optionsHead and neck squamous cell carcinomaWhite patientsNeck squamous cell carcinomaImproved survival of patientsCohort of elderly patientsImmune checkpoint inhibitorsMultivariate logistic regression analysisAdvanced stage diseaseSquamous cell carcinomaSurvival of patientsUnited States Food and Drug AdministrationStates Food and Drug AdministrationFood and Drug AdministrationLogistic regression analysisCommunity oncology settingStatistically significant differenceCheckpoint inhibitorsOropharyngeal cancerSystemic therapy